With respect to captioned subject, we wish to inform you that the Board of Directors in its Meeting held today has inter-alia, considered and approved the standalone and consolidated Un-Audited Financial Results for the half-year ended September 30, 2018. We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended as on 30.09.2018 along with the limited review report thereon.

Pdf Link: Kwality Pharmaceuticals Ltd - Submission Of Standalone And Consolidated Un-Audited Financial Results For The Half Year Ended On 30.09.2018

Source : BSE - www.bseindia.com

comment COMMENT NOW